Live
- BJP MP candidate Bharat Prasad visited the student who tried to commit suicide
- PM’s popularity in the fast lane: Autos with 'Har Dil Mein Modi' slogan spotted across Delhi
- Delhi-based political parties are like East India Company: Sukhbir Badal
- Golf: Diksha moves into Top-20 at South African Women’s Open
- KCR lashes out against BJP and Congress for destroying Telangana
- Dairy Science students visited the Milk cooling plant
- Moody feels Pant ahead in keepers’ race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
Dr Reddy's unveils osteoporosis drug
Hyderabad: Dr Reddy's Labs said it had launched generic Zoledronic Acid injection used for treating osteoporosis and Paget's disease of bone in the US...
Hyderabad: Dr Reddy's Labs said it had launched generic Zoledronic Acid injection used for treating osteoporosis and Paget's disease of bone in the US market. Osteoporosis is a disease of bones that leads to an increased risk of fracture while Paget's disease of bone is a chronic disorder that can result in enlarged and misshapen bones.
The company has launched Zoledronic Acid injection (5 mg/ 100 mL) on Wednesday following approval of its abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA), the company said in a release.
The injection is generic version of Novartis AG's Reclast injection in the same strength, it added. The Reclast brand had total US sales of approximately $355 million for the most recent twelve months ending February, 2013 according to IMS Health.
